Merck's Durham plant tagged for job growth
Merck has been steadily adding to its vaccine manufacturing plant in Durham, NC, and now says that it plans to hire up to 310 new workers there over the next two years. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
- Lucigen Corporation Awarded $2.8M SBIR Grant for Point of Care Diagnostics
- Blueprint Medicines Welcomes Fidelity Biosciences to Investor Syndicate
- Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro(TM) and announces changes to management
- Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease
- More Press Releases
Featured Jobs
-
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA -
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US -
Quality Assurance Scientist Job
Yoh - Brea, CA, USA -
Program Lead - Scientific Information Architecture & Search
Merck - Boston, MA -
Neurosciences Knowledge Group Lead
Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA
Comments